Ionis Pharmaceuticals Share Price Today
(NASDAQ: IONS)

Name: Ionis Pharmaceuticals Share Price Today (NASDAQ: IONS) - Ionis Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Ionis Pharmaceuticals share price is $32.32 & ₹2,802.98 as on 22 Feb 2025, 2.30 'hrs' IST

$32.32

▲

-0.37

(-1.13%)

Market is closed - opens 8 PM, 24 Feb 2025

View live Ionis Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Ionis Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ionis Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Ionis Pharmaceuticals share price movements

Today's Low: $32.00
Today's High: $32.87
$32.32
0.99%
Downside
Day's Volatility :2.63%
Upside
1.66%
52 Weeks Low: $30.23
52 Weeks High: $52.34
$32.32
6.47%
Downside
52 Weeks Volatility :42.24%
Upside
38.25%

Ionis Pharmaceuticals (IONS) Returns

Period	Ionis Pharmaceuticals, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-8.86%	1.6%	0.0%
6 Months	-30.94%	-5.8%	0.0%
1 Year	-29.89%	-1.0%	0.0%
3 Years	1.7%	15.7%	-9.0%

Ionis Pharmaceuticals (IONS) Key Statistics

in dollars & INR

Previous Close	$32.69
Open	$32.69
Today's High	$32.865
Today's Low	$32.0
Market Capitalization	$5.2B
Today's Volume	$1.6M
52 Week High	$52.34
52 Week Low	$30.23
Revenue TTM	$705.0M
EBITDA	$-462.7M
Earnings Per Share (EPS)	$-3.04
Profit Margin	-64.4%
Quarterly Earnings Growth YOY	-0.44%
Return On Equity TTM	-93.16%

How to invest in Ionis Pharmaceuticals Stock (IONS) from India?

It is very easy for Indian residents to invest directly in Ionis Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ionis Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ionis Pharmaceuticals or IONS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ionis Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ionis Pharmaceuticals shares which would translate to 0.027 fractional shares of Ionis Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ionis Pharmaceuticals, in just a few clicks!

Returns in Ionis Pharmaceuticals (IONS) for Indian investors in Rupees

The Ionis Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Ionis Pharmaceuticals investment value today

Current value as on today

₹74,758

Returns

₹25,242

(-25.24%)

Returns from Ionis Pharmaceuticals Stock

₹29,892 (-29.89%)

Dollar Returns

₹4,649 (+4.65%)

Indian investors sentiment towards Ionis Pharmaceuticals (IONS)

-55%

Period: Jan 24, 2025 to Feb 23, 2025. Change in 30 Days versus previous period

Search interest for Ionis Pharmaceuticals Stock from India on INDmoney has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Ionis Pharmaceuticals

FMR Inc
14.24%
Vanguard Group Inc
10.43%
T. Rowe Price Investment Management,Inc.
8.97%
Capital World Investors
7.26%
BlackRock Inc
6.85%
Wellington Management Company LLP
5.49%

Analyst Recommendation on Ionis Pharmaceuticals

Buy

66%Buy

23%Hold

10%Sell

Based on 30 Wall street analysts offering stock ratings for Ionis Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 30 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Ionis Pharmaceuticals Stock (IONS)

What analysts predicted

Upside of 86.26%

Target:

$60.20

Current:

$32.32

Insights on Ionis Pharmaceuticals Stock (Ticker Symbol: IONS)

Price Movement
In the last 7 days, IONS stock has moved up by 4.1%
Increasing Revenue
Revenue is up for the last 2 quarters, 134.0M → 226.57M (in $), with an average increase of 40.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -140.48M → -104.34M (in $), with an average increase of 34.6% per quarter
IONS vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 59.0% return, outperforming this stock by 87.7%
IONS vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 69.9% return, outperforming this stock by 64.7%
Price to Sales
ForIONS every $1 of sales, investors are willing to pay $6.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Ionis Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Ionis Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Ionis Pharmaceuticals (IONS) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Ionis Pharmaceuticals, Inc.	-6.99%	-30.94%	-29.89%	1.7%	-42.31%
Biontech Se	1.58%	37.14%	28.33%	-20.32%	255.59%
Regeneron Pharmaceuticals, Inc.	3.63%	-41.61%	-29.21%	13.2%	52.94%
Vertex Pharmaceuticals Incorporated	10.15%	0.33%	11.71%	110.26%	108.69%
Alnylam Pharmaceuticals, Inc.	-10.11%	-6.89%	57.94%	61.67%	112.27%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Ionis Pharmaceuticals, Inc.	524.14	NA	25.7	-2.92	-0.93	-0.1	NA	3.72
Biontech Se	160.8	NA	0.04	-3.29	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	18.16	18.16	1.01	43.09	0.16	0.07	0.01	273.57
Vertex Pharmaceuticals Incorporated	32.84	NA	1.3	18.11	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.59	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Ionis Pharmaceuticals, Inc.	Buy	$5.2B	-42.31%	524.14	-64.4%
Biontech Se	Buy	$28.3B	255.59%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$76.1B	52.94%	18.16	31.07%
Vertex Pharmaceuticals Incorporated	Buy	$123.3B	108.69%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$32.5B	112.27%	NA	-12.37%

About Ionis Pharmaceuticals

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was incorporated in 1989 and is based in Carlsbad, California.

Organization	Ionis Pharmaceuticals
Employees	1069
CEO	Dr. Brett P. Monia Ph.D.
Industry	Health Technology

Management People of Ionis Pharmaceuticals

Name	Title
Dr. Brett P. Monia Ph.D.	Founder, CEO & Director
Ms. Elizabeth L. Hougen M.A., M.B.A., M.S.	Executive VP of Finance & CFO

Important FAQs about investing in IONS Stock from India :

What is Ionis Pharmaceuticals share price today?

Ionis Pharmaceuticals share price today stands at $32.32, Open: $32.69 ; Previous Close: $32.69 ; High: $32.87 ; Low: $32.00 ; 52 Week High: $52.34 ; 52 Week Low: $30.23.

The stock opens at $32.69, after a previous close of $32.69. The stock reached a daily high of $32.87 and a low of $32.00, with a 52-week high of $52.34 and a 52-week low of $30.23.

Can Indians buy Ionis Pharmaceuticals shares?

Yes, Indians can invest in the Ionis Pharmaceuticals (IONS) from India.

With INDmoney, you can buy Ionis Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Ionis Pharmaceuticals at zero transaction cost.

How can I buy Ionis Pharmaceuticals shares from India?

It is very easy to buy Ionis Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ionis Pharmaceuticals (IONS) be purchased?

Yes, you can buy fractional shares of Ionis Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Ionis Pharmaceuticals stocks?

To start investing in Ionis Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.